DGE 3rd Diversity in Clinical Trials Invites Pharmaceutical Professionals for Enlightening Discussions

April 18, 2024 at 12:05 PM EDT

DGE invites life science professionals to attend the 3rd Diversity In Clinical Trials Conference being held on May 15-16, 2024 at the Inn at Penn Philadelphia. The conference offers an valuable forum for meaningful interactions to understand the intricacies of and benefits of pursuing diverse enrollment in clinical studies.

The event is hosted by Dynamic Global Events (“DGE”), a global leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the…

To learn more please visit https://ibn.fm/EBGQd.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]